These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3250014)

  • 1. Binding properties of progesterone-binding Cyst protein, PBCP.
    Lea OA
    Steroids; 1988 Oct; 52(4):337-8. PubMed ID: 3250014
    [No Abstract]   [Full Text] [Related]  

  • 2. Progesterone-binding cyst protein in human breast tumor cytosol.
    Lea OA; Kvinnsland S; Thorsen T
    Cancer Res; 1987 Dec; 47(23):6189-92. PubMed ID: 3677070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?
    Søreide JA; Lea OA; Kvinnsland S
    Breast Cancer Res Treat; 1987; 9(2):123-8. PubMed ID: 3620714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone-binding cyst protein (PBCP) in operable breast cancer: correlations with prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
    Søreide JA; Lea OA; Anda O; Skarstein A; Varhaug JE; Kvinnsland S
    Anticancer Res; 1991; 11(2):601-5. PubMed ID: 2064314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
    Søreide JA; Lea OA; Kvinnsland S
    Anticancer Res; 1991; 11(3):1323-6. PubMed ID: 1888167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone binding cyst protein in hormone receptor positive breast cancer; a predictive factor for effect of adjuvant tamoxifen treatment.
    Søreide JA; Kolnes J; Skarstein A; Aas T; Kvinnsland S
    Anticancer Res; 1994; 14(5B):2105-8. PubMed ID: 7840507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor and prolactin in human breast cyst fluid. Possible correlations with GCDFP-15.
    Collette J; Van Cauwenberge JR; Dejardin L; Carlisi A; Jaspar JM; Franchimont P
    Ann N Y Acad Sci; 1990; 586():146-57. PubMed ID: 2356996
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease.
    Balbín M; Freije JM; Fueyo A; Sánchez LM; López-Otín C
    Biochem J; 1990 Nov; 271(3):803-7. PubMed ID: 2244881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation from a human seminal vesicle library of the cDNA for gp17, a CD4 binding factor.
    Autiero M; Bouchier C; Basmaciogullari S; Zaborski P; el Marhomy S; Martin M; Guardiola J; Piatier-Tonneau D
    Immunogenetics; 1997; 46(4):345-8. PubMed ID: 9218538
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
    Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
    Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of GCDFP-15. An apocrine marker protein.
    Haagensen DE; Dilley WG; Mazoujian G; Wells SA
    Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
    [No Abstract]   [Full Text] [Related]  

  • 12. The biochemistry of cyst fluids.
    Miller WR
    Br J Clin Pract Suppl; 1989 Nov; 68():94-9; discussion 111-5. PubMed ID: 2488573
    [No Abstract]   [Full Text] [Related]  

  • 13. TaqI and RsaI RFLP's at the prolactin inducible protein (PIP) locus on chromosome 7.
    Myal Y; Gregory CA; Karpan C; Hamerton JL; Shiu RP
    Nucleic Acids Res; 1989 Jul; 17(14):5879. PubMed ID: 2569729
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia.
    Caputo E; Autiero M; Mani JC; Basmaciogullari S; Piatier-Tonneau D; Guardiola J
    Int J Cancer; 1998 Sep; 78(1):76-85. PubMed ID: 9724097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium.
    Mazoujian G; Warhol MJ; Haagensen DE
    Am J Pathol; 1984 Aug; 116(2):305-10. PubMed ID: 6205595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoperoxidase staining for tumor markers in patients with carcinoma of the breast.
    Cox CE; Haagensen DE; Dilley WG; Wells SA
    Surg Forum; 1978; 29():160-2. PubMed ID: 401405
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is there value in determining tumor markers in senology?].
    Van Cauwenberge JR; Collette J; Franchimont P
    Rev Med Liege; 1995 Jan; 50(1):41-5. PubMed ID: 7871286
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells.
    Simard J; Veilleux R; de Launoit Y; Haagensen DE; Labrie F
    Cancer Res; 1991 Aug; 51(16):4336-41. PubMed ID: 1868457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
    Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
    Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunopathology of gross cystic disease fluid proteins.
    Mazoujian G; Haagensen DE
    Ann N Y Acad Sci; 1990; 586():188-97. PubMed ID: 2357000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.